Prentiss Smith & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,124
| Closed | -$156K | – | 250 |
|
|
2018
Q3 | $156K | Buy |
1,124
+9
| +0.8% | +$1.25K | 0.09% | 65 |
|
|
2018
Q2 | $138K | Sell |
1,115
-1,359
| -55% | -$168K | 0.08% | 72 |
|
|
2018
Q1 | $276K | Buy |
2,474
+2,465
| +27,389% | +$275K | 0.14% | 68 |
|
|
2017
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 295 |
|
|
2017
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 240 |
|
|
2017
Q2 | $1K | Sell |
9
-391
| -98% | -$43.4K | ﹤0.01% | 247 |
|
|
2017
Q1 | $48K | Sell |
400
-9
| -2% | -$1.08K | 0.03% | 114 |
|
|
2016
Q4 | $50K | Hold |
409
| – | – | 0.03% | 117 |
|
|
2016
Q3 | $50K | Hold |
409
| – | – | 0.03% | 121 |
|
|
2016
Q2 | $48K | Sell |
409
-14
| -3% | -$1.64K | 0.03% | 121 |
|
|
2016
Q1 | $59K | Hold |
423
| – | – | 0.03% | 115 |
|
|
2015
Q4 | $81K | Buy |
423
+23
| +6% | +$4.4K | 0.04% | 103 |
|
|
2015
Q3 | $63K | Sell |
400
-9
| -2% | -$1.42K | 0.03% | 108 |
|
|
2015
Q2 | $74K | Hold |
409
| – | – | 0.04% | 108 |
|
|
2015
Q1 | $71K | Buy |
409
+9
| +2% | +$1.56K | 0.03% | 114 |
|
|
2014
Q4 | $74K | Buy |
400
+367
| +1,112% | +$67.9K | 0.03% | 114 |
|
|
2014
Q3 | $5K | Hold |
33
| – | – | ﹤0.01% | 211 |
|
|
2014
Q2 | $5K | Hold |
33
| – | – | ﹤0.01% | 213 |
|
|
2014
Q1 | $5K | Hold |
33
| – | – | ﹤0.01% | 226 |
|
|
2013
Q4 | $4K | Buy |
+33
| New | +$4K | ﹤0.01% | 224 |
|